Search
CRISPR Therapeutics AG
CRSPAdd to Watchlist
47.640USD
+0.090+0.19%
Close 07-29 16:00（ET）Quotes delayed by 15 min
4.59BMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-29The current institutional shareholding score of CRISPR Therapeutics AG is 7.00, ranking 80 out of 384 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.16%, representing a quarter-over-quarter decrease of 7.94%. The largest institutional shareholder is Catherine Wood, holding a total of 10.05M shares, representing 11.74% of shares outstanding, with 0.08% increase in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Orbis Investment Management Ltd.
State Street Investment Management (US)
T. Rowe Price Investment Management, Inc.
GSK plc
Geode Capital Management, L.L.C.
George (Simeon J.)
SR One Capital Management, LP
Fidelity Management & Research Company LLC
1
2